DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.

ABSTRACT: Antitumor therapeutic strategies that fundamentally rely on the induction of DNA damage to eradicate and inhibit the growth of cancer cells are integral approaches to cancer therapy. Although DNA-damaging therapies advance the battle with cancer, resistance, and recurrence following treatment are common. Thus, searching for vulnerabilities that facilitate the action of DNA-damaging agents by sensitizing cancer cells is an active research area. Therefore, it is crucial to decipher the detailed molecular events involved in DNA damage responses (DDRs) to DNA-damaging agents in cancer. The tumor suppressor p53 is active at the hub of the DDR. Researchers have identified an increasing number of genes regulated by p53 transcriptional functions that have been shown to be critical direct or indire

SUBMITTER: Abuetabh Y 

PROVIDER: S-EPMC9636249 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature